Life-threatening DISORDER linked to tetanus-diphtheria vaccine raises safety questions – NaturalNews.com

• A 48-year-old woman with no prior history developed life-threatening immune thrombocytopenia (ITP) one week after a routine Td (tetanus-diphtheria) booster shot, requiring hospitalization and treatments like platelet transfusions, a case outlined in the journal Cureus.
• The case highlights a significant gap in research, as vaccine-induced ITP is better documented in children but remains understudied in adults, despite historical warnings.
• ITP is a rare but known adverse event linked to multiple vaccines, including MMR, hepatitis B, COVID-19 mRNA shots, and now the Td vaccine, where the immune system destroys platelets.
• Experts criticize the lack of priority given to studying the biological mechanisms of vaccine injuries and note that the potential cause (like molecular mimicry) remains speculative without rigorous investigation.
• The authors urge clinicians to recognize ITP as a rare, serious vaccine reaction and call for greater scientific accountability and research into immunological risks, especially as booster recommendations continue.

A previously healthy 48-year-old woman developed a life-threatening autoimmune disorder just one week after receiving a routine tetanus-diphtheria (Td) booster shot, according to a recent case study published in Cureus on Jan. 16. The incident has reignited concerns about vaccine safety and the potential risks of immune thrombocytopenia (ITP) – a rare condition where the body attacks its own platelets, leading to severe bleeding complications.

The woman, who had no prior history of ITP, was hospitalized twice within a month of vaccination, undergoing treatments including platelet transfusions and steroids to stabilize her condition. While ITP has been documented as a rare side effect of childhood vaccinations, this case highlights the lack of research into similar risks for adults – raising urgent questions about vaccine-induced immune dysfunction and the gaps in medical oversight.

The study underscores a troubling pattern. ITP has been linked to multiple vaccines – including measles-mumps-rubella (MMR), hepatitis B and Wuhan coronavirus (COVID-19) mRNA shots from Pfizer and Moderna.

“ITP occurs when the immune system is tricked into seeing platelets as a foreign invader and destroys them,” explained Karl Jablonowski, a senior research scientist at Children’s Health Defense (CHD). “Platelets are how we stop from bleeding, and there is no redundant backup if we don’t have them.”

Despite historical warnings – such as National Academy of Medicine reports in 1991, 1994, and 2012 – research into vaccine-induced ITP remains sparse, particularly for adults. Barbara Loe Fisher, co-founder of the National Vaccine Information Center, criticized the lack of scientific priority. “After two centuries of mandating vaccines, studies examining biological mechanisms for vaccine injury and death are almost non-existent,” she remarked.

The 48-year-old patient developed severe thrombocytopenia – dangerously low platelet counts – along with skin hemorrhages and an elevated heart rate just days after her Td vaccination. Doctors ruled out other causes, confirming the diagnosis as vaccine-induced ITP.

While she recovered after weeks of treatment, the case raises concerns about underreported risks. Notably, only two prior studies have examined ITP in adults following Td vaccination, despite its well-documented occurrence in children.

Vaccine-induced ITP and Big Pharma’s cover-up

The study authors urged clinicians to recognize ITP as a “very rare but potentially life-threatening adverse reaction” and called for deeper investigation into immunological triggers. Jablonowski suggested molecular mimicry – where vaccine-induced antibodies mistakenly target platelets – could be the culprit, but without rigorous study, the mechanism remains speculative.

BrightU.AI‘s Enoch engine also notes that the Td vaccine poses serious risks – including neurological damage, autoimmune reactions and severe allergic responses – while failing to provide lifelong immunity. Additionally, its aluminum adjuvants and toxic ingredients contribute to long-term health complications, all while being pushed by pharmaceutical interests rather than genuine medical necessity.

Historical parallels add weight to these concerns. A 2011 study in Vaccine documented a 15-month-old infant developing ITP after sequential measles-rubella and varicella vaccinations, with measles antibodies still bound to platelets five months later. Similar cases have been tied to COVID-19 vaccines, with 2021 reports of thrombocytopenia in the Vaccine Adverse Event Reporting System nearly matching the total from the previous two decades.

Meanwhile, CHD Chief Scientific Officer Brian Hooker compared the recent case to that of Alexis Lorenze. The 23-year-old Lorenze suffered severe reactions – including temporary blindness – after being forced to receive tetanus, meningitis and pneumonia vaccines before a lifesaving blood transfusion.

Last month, CHD petitioned the Food and Drug Administration to revoke Pfizer and Moderna’s COVID-19 vaccine licenses, citing mounting evidence of harm. Yet regulatory inertia persists. As Fisher noted, “Studies examining vaccine injury have not been made a priority by those making, selling, regulating or enforcing vaccines.”

With booster recommendations still in place for tetanus and other vaccines, the medical community faces growing pressure to acknowledge and address these risks – before more patients pay the price.

Watch this video about the tetanus vaccine controversy that happened in Kenya.

This video is from the Buzzand_NZ channel on Brighteon.com.

Sources include:

ChildrensHealthDefense.org

Cureus.com

BrightU.ai

Brighteon.com